Advances in molecular characterization of myeloid proliferations associated with Down syndrome

Myeloid leukemia associated with Down syndrome (ML-DS) has a unique molecular landscape that differs from other subtypes of acute myeloid leukemia. ML-DS is often preceded by a myeloproliferative neoplastic condition called transient abnormal myelopoiesis (TAM) that disrupts megakaryocytic and eryth...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jixia, Kalev-Zylinska, Maggie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399805/
https://www.ncbi.nlm.nih.gov/pubmed/36035173
http://dx.doi.org/10.3389/fgene.2022.891214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399805/
https://www.ncbi.nlm.nih.gov/pubmed/36035173
http://dx.doi.org/10.3389/fgene.2022.891214

Ejemplares similares